RPL32 and lung carcinoma: One study examined whether RPL32 was associated with cisplatin sensitivity in the lung cancer cell lines A549, NCI‐H460, and H1299 and showed that knockout of RPL32 significantly increased cisplatin sensitivity in A549 and NCI‐H460 cells.11